These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


317 related items for PubMed ID: 8311491

  • 21. MRI of high-grade astrocytic tumors: early appearance and evolution.
    Okamoto K, Ito J, Takahashi N, Ishikawa K, Furusawa T, Tokiguchi S, Sakai K.
    Neuroradiology; 2002 May; 44(5):395-402. PubMed ID: 12012123
    [Abstract] [Full Text] [Related]

  • 22. Surrounding muscle edema detected by MRI is valuable for diagnosis of intramuscular myxoma.
    Nishimoto K, Kusuzaki K, Matsumine A, Seto M, Fukutome K, Maeda M, Hosoi S, Uchida A.
    Oncol Rep; 2004 Jan; 11(1):143-8. PubMed ID: 14654917
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [A case of high grade astrocytoma arising in the hand area of precentral gyrus].
    Nishibayashi H, Matsuda Y, Uematsu Y, Nakao N, Terada T, Itakura T.
    No To Shinkei; 2005 Jun; 57(6):517-22. PubMed ID: 16026048
    [Abstract] [Full Text] [Related]

  • 27. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R, Müller M, Dietz K, Duffner F, Bornemann A, Roser F, Tatagiba M.
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [Abstract] [Full Text] [Related]

  • 28. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
    Zhou WN, Chen ZP, You C, Mu YG, Sai K, Zhang JY, Zhang XH, Cheng JJ, Xu HC.
    Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
    [Abstract] [Full Text] [Related]

  • 32. [MRI abnormalities of the brain in neurologic complications following treatment of cancer in children].
    Tomura N, Sashi R, Hashimoto M, Hirano H, Sato K, Hirano Y, Watarai J, Watanabe A.
    No To Shinkei; 1996 Jul; 48(7):623-30. PubMed ID: 8752996
    [Abstract] [Full Text] [Related]

  • 33. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Yamamoto M, Fukushima T, Hayashi S, Ikeda K, Tsugu H, Kimura H, Soma G, Tomonaga M.
    Anticancer Res; 2000 Jul; 20(1C):611-8. PubMed ID: 10769704
    [Abstract] [Full Text] [Related]

  • 34. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP, Bachert P, Hamprecht F, Weber MA, Debus J, Schulz-Ertner D, Schlemmer HP, Kauczor HU.
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [Abstract] [Full Text] [Related]

  • 35. [Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].
    Masada T, Matsumoto Y, Kawai N, Tamiya T, Nagao S.
    No Shinkei Geka; 2004 Aug; 32(8):859-64. PubMed ID: 15478653
    [Abstract] [Full Text] [Related]

  • 36. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O.
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.